These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7958138)

  • 1. A new approach to treatment of the patients with PCOD.
    Meden-Vrtovec H
    Eur J Obstet Gynecol Reprod Biol; 1994 May; 55(1):36-7. PubMed ID: 7958138
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.
    Armitage M; Wilkin T; Dewbury K
    Br Med J (Clin Res Ed); 1987 Jul; 295(6590):96. PubMed ID: 3113653
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatomedin and somatostatin in polycystic ovary syndrome].
    Huber JC
    Gynakol Rundsch; 1991; 31 Suppl 2():66-8. PubMed ID: 1686431
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevtion of serum testosterone in ovarian hyperstimulation syndrome.
    Schumert Z; Spitz I; Diamant Y; Polishuk WZ; Rabinowitz D
    J Clin Endocrinol Metab; 1975 May; 40(5):889-92. PubMed ID: 1127095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of gonadotropin response to luteinizing hormone--releasing hormone in amenorrheic women.
    Crosignani PG; Reschini E; D'Alberton A; Trojsi L; Cantalamessa L; Giustina G
    Am J Obstet Gynecol; 1974 Oct; 120(3):376-84. PubMed ID: 4607337
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothalmic-pituitary relationships in the polycystic ovary syndrome serum gonadotrophin levels following injection of oestradiol benzoate.
    Shaw RW; Duignan NM; Butt WR; Edwards RL; London DR
    Br J Obstet Gynaecol; 1975 Dec; 82(12):952-7. PubMed ID: 1106757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ovarian wedge resection and incision on circulating gonadotropin in patients with polycystic ovarian disease.
    Tanaka T; Fujimoto S; Kutsuzawa T
    Int J Fertil; 1978; 23(2):93-9. PubMed ID: 30730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hormonal profile in the polycystic ovary syndrome].
    Donát J; Kohoutek M; Donátová N; Lacinová V
    Cesk Gynekol; 1989 Nov; 54(9):684-8. PubMed ID: 2516481
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrinological environment of polycystic ovarian disease.
    Tanaka T; Fujimoto S
    Horm Res; 1990; 33 Suppl 2():5-9. PubMed ID: 2128882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment.
    Genazzani AD; Battaglia C; Gamba O; Petraglia F; Malavasi B; Genazzani AR
    J Assist Reprod Genet; 2000 May; 17(5):269-75. PubMed ID: 10976414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal luteinizing hormone response patterns to synthetic gonadotrophin releasing hormone in patients with polycystic ovarian syndrome.
    Katz M; Carr PJ
    J Endocrinol; 1976 Aug; 70(2):163-71. PubMed ID: 787466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
    Vulkov I
    Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal correlations in the polycystic ovary syndrome.
    Messina M; Milani P; Gentile L
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):31-5. PubMed ID: 3087390
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
    Burger CW; Hompes PG; Korsen TJ; Schoemaker J
    Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.